Finance And Related Services Tenders

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Nitisinone, (Obo) Atc A16ax04 for the Period March 1St, 2025 - February 28Th, 2027

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Ustekinumab, (Obg) Atc L04ac05 for the Period March 1St, 2025 - February 28Th, 2027

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Atovaquone, (Obg) Atc P01ax06 for the Period March 1St, 2025 - February 28Th, 2027

Medicine Discount Contracts in Accordance with Section 130A Paragraph 8 Sgb V as Part of Open House Procedures

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Bempedoic Acid + Ezetimibe, (Obo) Atc C10ba10 for the Period March 1St, 2025 - February 28Th, 2027

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Pegfilgrastim, (Obo) Atc L03aa13 for the Period March 1St, 2025 - February 28Th, 2026 (Plus Extension Option 1X12 Months)

Imaginamics Center Research Building

Imaginamics Center Research Building

Dynamic Purchasing System of Supply of Equipment for Catering Operations and Cleaning Departments

Conference Facilities